|
Jeffrey L. Garwin, M.D., Ph.D., Director. Dr. Garwin has been with Biomoda, Inc., since 1993 as director. Mr. Garwin is currently the president, a position he has held since October 1998, of UltraTouch Corporation (Oct 1998), a medical device company developing technology to screen for breast tumors. Dr. Garwin was vice president of medical and quality assurance for Eggland's Best, a food products company, from 1990-1994. His previous experience also includes positions as director of science and technology for R.G. Vanderweil Engineers (working on biotechnology process engineering), assistant director of clinical research at McNeil Consumer Products Company (a major pharmaceutical company in the Johnson & Johnson family of companies, performing clinical studies on Imodium and other gastrointestinal products), and a staff scientist and project leader at Biogen. Biogen is one of the first biotechnology companies, and Dr. Garwin contributed to project teams in protein chemistry and microbiology. Dr. Garwin is listed in the premier edition of Who's Who in Science and Engineering as well as in American Men and Women of Science. He is an inventor of four independent U.S. biomedical patents, and is a widely published biomedical author. Dr. Garwin is the inventor of one patent application assigned to Biomoda Inc. Dr. Garwin holds a Ph.D. in biochemistry and an M.D., both from Yale University | 